The 5-Second Trick For pentobarbital sodium drug class
The 5-Second Trick For pentobarbital sodium drug class
Blog Article
pentobarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Coadministration of CYP3A4 inducers may decrease sufentanil stages and efficacy, possibly precipitating withdrawal syndrome in patients who've developed Bodily dependence to sufentanil. Discontinuation of concomitantly used CYP3A4 inducers may maximize sufentanil plasma concentration.
pentobarbital will minimize the extent or effect of osilodrostat by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
Contraindicated (1)pentobarbital will lower the level or effect of lonafarnib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is often a delicate CYP3A4 substrate. Coadministration with solid or moderate CYP3A4 inducers is contraindicated.
pentobarbital will decrease the extent or effect of verapamil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
Contraindicated (one)pentobarbital decreases levels of panobinostat by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Solid CYP3A4 inducers can minimize panobinostat concentrations by ~70% and bring about procedure failure.
pentobarbital will lower the level or effect of ritonavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
Particular client population: Dosage should be decreased inside the elderly or debilitated because these sufferers might be far more delicate to barbiturates. Dosage should be diminished for people with impaired renal function or hepatic sickness.
pentobarbital will minimize the level or effect of pimozide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unknown.
pentobarbital will minimize the level or effect of amiodarone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will reduce the level or effect of tamoxifen by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
Inspection: Parenteral drug products and solutions need to be inspected visually for particulate subject and discoloration just before administration, Anytime solution containers allow. Solutions for injection showing proof of precipitation should not be used.
Check here Intently (1)pentobarbital will lower the extent or effect of fentanyl by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Coadministration of fentanyl with CYP3A4 inducers could lead on to the reduce in fentanyl plasma concentrations, lack of efficacy or, quite possibly, improvement of a withdrawal syndrome in a very patient that has made physical dependence to fentanyl. Soon after halting a CYP3A4 inducer, given that the effects from the inducer decline, the fentanyl plasma concentration will enhance which could enhance or extend equally the therapeutic and adverse effects.
pentobarbital and olopatadine intranasal the two improve sedation. Avoid or Use Alternate Drug. Coadministration increases hazard of CNS depression, which can lead to additive impairment of psychomotor general performance and result in daytime impairment.
pentobarbital will decrease the extent or effect of eucalyptus by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Not known.